DE60032594T2 - Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie - Google Patents

Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie Download PDF

Info

Publication number
DE60032594T2
DE60032594T2 DE60032594T DE60032594T DE60032594T2 DE 60032594 T2 DE60032594 T2 DE 60032594T2 DE 60032594 T DE60032594 T DE 60032594T DE 60032594 T DE60032594 T DE 60032594T DE 60032594 T2 DE60032594 T2 DE 60032594T2
Authority
DE
Germany
Prior art keywords
pirenoxine
corneal
use according
ros
photokeratectomy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032594T
Other languages
German (de)
English (en)
Other versions
DE60032594D1 (de
Inventor
Enrico Boldrini
Mario Viale Pieraccini 6 Ciuffi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmigea Holding Srl It
Original Assignee
Farmigea SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea SpA filed Critical Farmigea SpA
Publication of DE60032594D1 publication Critical patent/DE60032594D1/de
Application granted granted Critical
Publication of DE60032594T2 publication Critical patent/DE60032594T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60032594T 1999-03-17 2000-03-13 Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie Expired - Lifetime DE60032594T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999RM000166A IT1305306B1 (it) 1999-03-17 1999-03-17 Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
ITRM990166 1999-03-17
PCT/IT2000/000081 WO2000054757A2 (en) 1999-03-17 2000-03-13 Use of pirenoxine for the protection of corneal tissues in photokeratectomy

Publications (2)

Publication Number Publication Date
DE60032594D1 DE60032594D1 (de) 2007-02-08
DE60032594T2 true DE60032594T2 (de) 2007-10-11

Family

ID=11406570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032594T Expired - Lifetime DE60032594T2 (de) 1999-03-17 2000-03-13 Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie

Country Status (10)

Country Link
US (1) US6610686B1 (https=)
EP (1) EP1173255B1 (https=)
JP (1) JP5167499B2 (https=)
AT (1) ATE349244T1 (https=)
AU (1) AU3324100A (https=)
DE (1) DE60032594T2 (https=)
ES (1) ES2277831T3 (https=)
IT (1) IT1305306B1 (https=)
PT (1) PT1173255E (https=)
WO (1) WO2000054757A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
CA2769090A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for providing laser shot patterns to the lens of an eye
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
WO2011011788A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
CN102843955A (zh) 2010-02-01 2012-12-26 雷萨公司 眼科应用中吸环基于浦肯野图像的对准
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
ES3064580T3 (en) 2010-10-15 2026-04-27 Lensar Inc Scan-controlled illumination of structures within an eye
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
EP2800812A1 (en) * 2012-01-04 2014-11-12 Quark Pharmaceuticals, Inc. Double-stranded rna compounds to casp2 and uses thereof
CN103211754A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的吡诺克辛钠滴眼液的生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181788A1 (en) * 1994-01-21 1995-07-27 Jonathan Javitt Cis-hydroxyproline analogs for eye treatment
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
IT1292103B1 (it) * 1997-06-06 1999-01-25 Pharmaconsult S A S Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
CN1291898A (zh) * 1998-02-25 2001-04-18 若素制药株式会社 用于角膜上皮疾病的药物

Also Published As

Publication number Publication date
ATE349244T1 (de) 2007-01-15
EP1173255B1 (en) 2006-12-27
ES2277831T3 (es) 2007-08-01
US6610686B1 (en) 2003-08-26
WO2000054757A3 (en) 2001-03-29
IT1305306B1 (it) 2001-05-04
WO2000054757A2 (en) 2000-09-21
DE60032594D1 (de) 2007-02-08
EP1173255A2 (en) 2002-01-23
PT1173255E (pt) 2007-03-30
ITRM990166A1 (it) 2000-09-17
AU3324100A (en) 2000-10-04
JP5167499B2 (ja) 2013-03-21
JP2002539153A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
DE60032594T2 (de) Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie
DE69626539T2 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69129078T2 (de) Aminosteroide zur Verwendung in der Augenheilkunde
DE69907664T2 (de) Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung
DE60100866T2 (de) Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
DE69326610T2 (de) Arzneimittel gegen glaukom
EP0567816A1 (de) Verwendung von Inhibitoren von Plasminogenaktivatoren zur Behandlung von Entzündungen und Wunden
EP1321138B1 (en) Coenzyme Q10 for the treatment of ocular diseases
EP0998925A1 (en) Medicinal compositions for topical administration containing vitamin d and vitamin k
US6248732B1 (en) Ophthalmological composition comprising activated vitamin D
DE68906213T2 (de) Intraokular-antikoagulans.
JPWO1996029079A1 (ja) 活性型ビタミンｄを配合した眼科用組成物
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE3330053C2 (https=)
DE10141018A1 (de) Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
DE69824853T2 (de) Zusammensetzung und Gegenstände zur Verminderung der Auswirkung von Entzündungen
US5196449A (en) Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
DE3750464T2 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
DE60005992T2 (de) Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien
DE69837622T2 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
RU2070010C1 (ru) Средство антиоксидантной защиты сред и тканей глаза
DE60131100T4 (de) Verfahren zur behandlung bestimmter augenkrankheiten
EP0719556B1 (en) Use of (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamide for treating diabetic keratopathy
WO1994005331A1 (de) Stabile hochkonzentrierte formulierungen von fluoresceinderivaten
DE69916330T2 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BOLDRINI, ENRICO, 56127 PISA, IT

Inventor name: CIUFFI, MARIO, VIALE PIERACCINI 6, 50134 FIREN, IT

8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 1173255

Country of ref document: EP

Owner name: FARMIGEA HOLDING S.R.L., IT

Free format text: FORMER OWNER: FARMIGEA S.P.A., PISA, IT

Effective date: 20120927

R082 Change of representative

Ref document number: 1173255

Country of ref document: EP

Representative=s name: V. BEZOLD & PARTNER, DE

Effective date: 20120927